Abstract
Microglia are monocyte-macrophage lineage cells, while other glial cells are neuroectodermal origin. Accumulation of microglia is commonly observed around degenerating neurons. There, microglia produce a variety of factors and function both neurotoxic and neuroprotective. Thus, accumulation of glia in various neurological disorders is not a static scar, gliosis, but more actively involved in degeneration and regeneration as neuroinflammation. We have shown previously that the most neurotoxic factor from activated microglia is glutamate, and that the suppression of glutamate release from microglia results in amelioration of disease progression in animal models of neurodegenerative disorders. On the other hands, when exposed to harmful stimuli, neurons also produce various factors as “help me” signals. Recently, we found that a CX3C chemokine, fractalkine (FKN), and interleukin-34 (IL-34) were secreted from damaged neurons. FKN and IL-34 differently activated microglia to rescue neurons by upregulating phagocytosis of toxicants or damaged debris, and production of anti-oxidant enzyme. The bi-directional interaction between neurons and microglia is important for understanding of chronic neuroinflammation, and gives us clues for future therapeutic strategy against neurodegenerative disorders.
Keywords: Neuron microglia, CNS, Neurodegenerative disorders, ALS
Current Protein & Peptide Science
Title:Neuron-Microglia Interaction in Neuroinflammation
Volume: 14 Issue: 1
Author(s): Akio Suzumura
Affiliation:
Keywords: Neuron microglia, CNS, Neurodegenerative disorders, ALS
Abstract: Microglia are monocyte-macrophage lineage cells, while other glial cells are neuroectodermal origin. Accumulation of microglia is commonly observed around degenerating neurons. There, microglia produce a variety of factors and function both neurotoxic and neuroprotective. Thus, accumulation of glia in various neurological disorders is not a static scar, gliosis, but more actively involved in degeneration and regeneration as neuroinflammation. We have shown previously that the most neurotoxic factor from activated microglia is glutamate, and that the suppression of glutamate release from microglia results in amelioration of disease progression in animal models of neurodegenerative disorders. On the other hands, when exposed to harmful stimuli, neurons also produce various factors as “help me” signals. Recently, we found that a CX3C chemokine, fractalkine (FKN), and interleukin-34 (IL-34) were secreted from damaged neurons. FKN and IL-34 differently activated microglia to rescue neurons by upregulating phagocytosis of toxicants or damaged debris, and production of anti-oxidant enzyme. The bi-directional interaction between neurons and microglia is important for understanding of chronic neuroinflammation, and gives us clues for future therapeutic strategy against neurodegenerative disorders.
Export Options
About this article
Cite this article as:
Suzumura Akio, Neuron-Microglia Interaction in Neuroinflammation, Current Protein & Peptide Science 2013; 14 (1) . https://dx.doi.org/10.2174/1389203711314010004
DOI https://dx.doi.org/10.2174/1389203711314010004 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Artificial Intelligence for Protein Research
Protein research, essential for understanding biological processes and creating therapeutics, faces challenges due to the intricate nature of protein structures and functions. Traditional methods are limited in exploring the vast protein sequence space efficiently. Artificial intelligence (AI) and machine learning (ML) offer promising solutions by improving predictions and speeding up ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Systems Biology of Apoptosis and Survival: Implications for Drug Development
Current Pharmaceutical Design Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review
Drug Delivery Letters Pharmacologic Strategies for Suppression of Lipid Peroxidation in Neurodegeneration
Current Neuropharmacology Phosphodiesterase-4 Modulation as a Potential Therapeutic for Cognitive Loss in Pathological and Non-Pathological Aging: Possibilities and Pitfalls
Current Pharmaceutical Design Parkinson Disease Genetics: A "Continuum" from Mendelian to Multifactorial Inheritance
Current Molecular Medicine Therapeutic Targets in the Ubiquitin-proteasome System for Alzheimer's Disease
Current Enzyme Inhibition The Neuroprotective Role of PEDF: Implication for the Therapy of Neurological Disorders
Current Molecular Medicine Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study
Current Topics in Medicinal Chemistry Lentiviral Transgenesis - A Versatile Tool for Basic Research and Gene Therapy
Current Gene Therapy Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight
Current Neuropharmacology Lipid Raft Alterations in Aged-Associated Neuropathologies
Current Alzheimer Research Recent Advancements in Liposome-Based Strategies for Effective Drug Delivery to the Brain
Current Medicinal Chemistry Antisynthetase Syndrome: A Review of Etiopathogenesis, Diagnosis and Management
Current Medicinal Chemistry Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection
Current Pharmaceutical Design Defects in RNA Metabolism links FTD and ALS Pathogenesis: TDP-43, FUS, and C9orf72
Current Enzyme Inhibition Molecular Pharmacology of the Glycine Receptor Chloride Channel
Current Pharmaceutical Design Editorial [ Hot topic: Aquaporins and Nervous System: from Bench to Bedside (Guest Editors: Rita Rezzani and Luigi F. Rodella) ]
Current Neuropharmacology The Multifunctional Anti-inflammatory Drugs Used in the Therapy of Alzheimer’s Disease
Current Medicinal Chemistry Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries
CNS & Neurological Disorders - Drug Targets The Contribution of Proteinase-Activated Receptors to Intracellular Signaling, Transcellular Transport and Autophagy in Alzheimer´s Disease
Current Alzheimer Research